# Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome

> **NCT00659321** · PHASE3 · COMPLETED · sponsor: **GWT-TUD GmbH** · enrollment: 68 (actual)

## Conditions studied

- Metabolic Syndrome
- Dyslipidaemia

## Interventions

- **DRUG:** nicotine acid
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00659321
- **Lead sponsor:** GWT-TUD GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-12
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2012-01-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659321, "Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00659321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*